IRVINE, Calif., July 20, 2017 -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that it will issue its 2017 second quarter earnings release on August 2, 2017.
A conference call with a simultaneous webcast to discuss the 2017 second quarter earnings will be held on Thursday, August 3 at 10:00 a.m. Pacific Time. The dial in number for the conference call is 877-741-4242 and participants should reference SABRA.
The webcast URL is http://edge.media-server.com/m/p/r7ssj4b3
A digital replay of the call will also be available for 30 days following the call, by dialing 888-203-1112 and using the passcode 3848697.
ABOUT SABRA
Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
Contact: Investor & Media Inquiries: (888) 393-8248


Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Apple Turns 50: From Garage Startup to AI Crossroads
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Britain Courts Anthropic Amid US Defense Department Dispute 



